DELRAY BEACH, Fla., Jan. 4, 2011 (GLOBE NEWSWIRE) — PositiveID
Corporation (“PositiveID”) (Nasdaq:PSID), the leader in next
generation patient monitoring, announced today that it has entered into an
agreement with Siemens AG (“Siemens”) related to its Wireless Body™
platform. The license agreement allows PositiveID to expand its personalized
medicine and smart healthcare applications for next generation patient
monitoring and includes granting PositiveID rights to utilize key intellectual
property, and, in particular, Siemens’ Patent No. 7,650,888, titled
“Method and System for Identification of a Medical Implant” using
RFID (radio frequency identification).
PositiveID’s focus is to use the technology to improve
disease management and overall wellness through the effortless identification
of implantable medical devices within the body. This application expands PositiveID’s
Wireless Body, an integrated, in vivo and external, smart healthcare
communication system that has the ability to deliver personalized medical
solutions wirelessly.
The Wireless Body communication system is based on PositiveID’s
Patent No. 7,125,382 for an Embedded Bio-Sensor System, and builds upon existing
technology and intellectual property portfolio of PositiveID, the developer of
the world’s first and only health-related implantable RFID microchip cleared by
the U.S. Food and Drug Administration. The Wireless Body platform will be
designed to enhance wellness and disease management, for diabetes and other
chronic illnesses, by allowing healthcare systems to communicate with each
other and monitor patients seamlessly.
Scott R. Silverman, Chairman and CEO of PositiveID, said,
“We are excited for this opportunity to work together with Siemens and
employ their patented technology to rapidly develop our Wireless Body platform.
We believe that we are well positioned as a next generation leader in mobile
health and personalized sensor tools, with the ability to wirelessly monitor
patients, their vital signs and their medical devices via The Wireless
Body.”
The Wireless Body also has the ability to identify medical
devices, currently catheter ports, to allow them to communicate with an
external reader to ensure proper medication dosages and safety for the patient.
About Siemens AG
Siemens AG (Berlin and Munich) is a global
powerhouse in electronics and electrical engineering, operating in the
industry, energy and healthcare sectors. For over 160 years, Siemens has stood
for technological excellence, innovation, quality, reliability and
internationality. The company is the world’s largest provider of environmental
technologies, generating some €28 billion – more than one-third of its total
revenue – from green products and solutions. In fiscal 2010, which ended on September
30, 2010, revenue totaled €76 billion and net income €4.1 billion. At the end
of September 2010, Siemens had around 405,000 employees worldwide. Further
information is available on the Internet at: www.siemens.com.
About PositiveID Corporation
PositiveID Corporation develops and markets healthcare and
information management products through its RFID-based diagnostic devices and
identification technologies, and its proprietary disease management tools. PositiveID’s
implantable healthcare devices and external hardware and software products are
designed to communicate wirelessly to improve healthcare and the patient’s
quality of life. For more information on PositiveID, please visit www.positiveidcorp.com.
